Abiraterona en Cáncer de Próstata hormonosensible metastático (castration-naive )

4 / 85

ADT + docetaxel: a new standard of care for men with mCNPC and high metastatic burden (2015)
Presented By Karim Fizazi at 2017 ASCO Annual Meeting